Dr. Spillman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St 793
Little Rock, AR 72205Phone+1 501-686-5827Fax+1 501-686-8091
Education & Training
- Duke University HospitalFellowship, Gynecologic Oncology, 2003 - 2006
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1999 - 2003
- University of Texas Southwestern Medical SchoolClass of 1999
Certifications & Licensure
- TX State Medical License 2009 - 2026
- AR State Medical License 2023 - 2025
- CO State Medical License 2006 - 2015
- NC State Medical License 2003 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy Start of enrollment: 2010 Feb 01
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 2 citationsOvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.David N Buckley, Juan Pablo Lewinger, Gerald Gooden, Monique Spillman, Monica Neuman
Clinical Cancer Research. 2023-12-15 - 2 citationsMAID ready for primetime?: A survey of SGO members regarding medical aid in dying (MAID)Alaina J. Brown, Nefertiti duPont, Ronald D. Alvarez, Monique A. Spillman, Lisa M. Landrum
Gynecologic Oncology Reports. 2021-08-01 - 16 citationsOCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.Raju Kandimalla, Wei Wang, Fan Yu, Nianxin Zhou, Feng Gao
Clinical Cancer Research. 2021-05-25
Journal Articles
- CBX2 Identified as Driver of Anoikis Escape and Dissemination in High Grade Serous Ovarian CancerMonique A Spillman, Kian Behbakht, Miriam D Post, Amber A Berning, Nature
Press Mentions
- What Doctors Wish Patients Knew About Inflammatory Bowel DiseaseJanuary 6th, 2023
- Gynecologic Cancer Clinicians and Researchers Recognized at SGO 2022 Annual Meeting on Women’s CancerMarch 21st, 2022
- Cancer Mortality Rates Reach Record LowFebruary 7th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: